A Q3 2022 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+8.3% YoY

Gross Profit

$939M54.7% margin

Operating Income

$411M23.9% margin

Net Income

$329M19.2% margin

EPS (Diluted)

$1.10

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

$326M

Free Cash Flow

$244M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$10.5B

Total Liabilities

$5.4B

Stockholders' Equity

$5.1B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+8.3%
Gross Profit	$939M	$852M	+10.2%
Operating Income	$411M	$336M	+22.3%
Net Income	$329M	$264M	+24.6%

Revenue Segments

Life Sciences and Applied Markets

$1.0B59%

Agilent CrossLab

$359M21%

Diagnostics and Genomics

$340M20%

Geographic Segments

Americas

$671M39%

Asia Pacific

$640M37%

Europe

$407M24%